Cold & Cough Remedies (Pharmacies) - Fiji

Revenue in the Cold & Cough Remedies market is projected to reach US$579.30k in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.64%, resulting in a market volume of US$836.90k by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$0.61 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Fiji has been experiencing significant growth in recent years.

Customer preferences: Customers in Fiji have shown a growing preference for over-the-counter cold and cough remedies available in pharmacies. This can be attributed to the convenience and accessibility of these products. Customers appreciate the ability to easily purchase these remedies without a prescription, allowing them to quickly address their cold and cough symptoms. Additionally, customers in Fiji tend to trust the recommendations of pharmacists, further driving their preference for purchasing these remedies from pharmacies.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Fiji is the increasing demand for natural and herbal remedies. Customers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceutical remedies. This trend aligns with the global shift towards natural and holistic healthcare solutions. As a result, pharmacies in Fiji are expanding their product offerings to include a wider range of natural and herbal cold and cough remedies to cater to this growing customer demand. Another trend in the market is the rising popularity of combination remedies. Customers in Fiji are increasingly seeking products that provide relief for multiple symptoms at once, such as cold and cough medicines that also address congestion or sore throat. This trend reflects the desire for convenience and efficiency in managing cold and cough symptoms. Pharmacies are responding to this trend by stocking a variety of combination remedies to meet customer needs.

Local special circumstances: Fiji's tropical climate and high humidity levels create an environment conducive to the spread of cold and cough viruses. This, coupled with the country's close proximity to other countries in the Pacific region, makes Fiji particularly susceptible to outbreaks of respiratory illnesses. As a result, there is a constant demand for cold and cough remedies in the market. The local special circumstances of Fiji's climate and geographical location contribute to the steady growth of the Cold & Cough Remedies (Pharmacies) market in the country.

Underlying macroeconomic factors: Fiji has experienced steady economic growth in recent years, resulting in an increase in disposable income among the population. This has positively impacted the Cold & Cough Remedies (Pharmacies) market, as customers have more purchasing power to spend on healthcare products. Additionally, the government of Fiji has been investing in improving healthcare infrastructure and services, which has further contributed to the growth of the market. These underlying macroeconomic factors have created a favorable environment for the development of the Cold & Cough Remedies (Pharmacies) market in Fiji.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.